regulatory approval

News

AZ's Truqap and Roche assay cleared for PTEN prostate cancer

AstraZeneca has claimed a second approval for AKT inhibitor Truqap, in prostate cancer, that should help achieve its blockbuster hopes for the drug.

News

UK approves Novo Nordisk's Wegovy pill

Novo Nordisk's fast-growing Wegovy pill has been approved in the UK for weight loss, its first European market.

News

Lilly wins new FDA approval for eczema drug Ebglyss

Lilly's Ebglyss has claimed an FDA approval for less-frequent maintenance dosing that could give it an edge over market leader Dupixent.

News

Ahead of ASCO data drop, AZ gets key Imfinzi approval

AstraZeneca has claimed another key FDA approval for Imfinzi in bladder cancer, as an add-on to BCG therapy for early non-muscle invasive disease.

News

AbbVie's Immunogen buy delivers rare cancer drug approval

AbbVie's Decnupaz approval will give patients with rare blood cancer BPDCN an alternative to Stemline's Elzonris with a simpler dosing regimen.

News

Datroway is first TROP2 drug for frontline breast cancer

AZ and Daiichi's Datroway has been cleared by the FDA as first-line treatment for triple-negative breast cancer patients ineligible for immunotherapy.

AZ's Truqap and Roche assay cleared for PTEN prostate cancer

UK approves Novo Nordisk's Wegovy pill

Lilly wins new FDA approval for eczema drug Ebglyss

Ahead of ASCO data drop, AZ gets key Imfinzi approval

AbbVie's Immunogen buy delivers rare cancer drug approval

Datroway is first TROP2 drug for frontline breast cancer

AI agents can beat doctors in clinical decision-making

Discover a new era of healthcare panel engagement: Grounded ...

regulatory approval

Editor's Picks